Sangeeta Wagner
Family Medicine · Sparks, NVNPI 1205809365
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (54.3%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by GSK at 57.0% of the total. Reporting peaked in 2024 at $7,598 and has fallen 97.8% since, to $167 in 2025. Among family medicine clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 40 payments — averaging $207.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$5K
- Modernatx, Inc.$2K
- Novartis$1K
- AstraZeneca$147
- Novo Nordisk$125
- Johnson & Johnson$104
- plus $247 from 8 others
Across 83 payments — averaging $10,498 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$515K
- Eli Lilly$172K
- Merck$84K
- Novartis$41K
- Pfizer$33K
- AstraZeneca$20K
- plus $6K from 1 others
What the payments were for
- Consulting fees$4,50054%
- Travel & lodging$2,20527%
- Food & beverage$1,58419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 5 | $4,723 |
| Modernatx, Inc. | 9 | $1,725 |
| Novartis | 7 | $1,219 |
| AstraZeneca | 4 | $147 |
| Novo Nordisk | 4 | $125 |
| Johnson & Johnson | 1 | $104 |
| Si-bone, Inc. | 1 | $72 |
| Edwards Lifesciences | 2 | $38 |
| Biohaven Pharmaceuticals, Inc. | 2 | $37 |
| Supernus Pharmaceuticals, Inc. | 1 | $32 |
| Organon | 1 | $24 |
| Lilly USA, LLC | 1 | $17 |
| Pfizer | 1 | $14 |
| Alnylam Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INVOKANA$104
How this compares
$8,289 in reported general payments places this provider in the 95th percentile of 902 family medicine providers in Nevada.
Other family medicine in Sparks
- Ronald HicksSparks$9K
- Naz WahabLas Vegas$563K
- Jerry CadeLas Vegas$180K
- Nilesh GokalLas Vegas$75K
- Bayo Curry-WinchellReno$74K
- Warren MagnusLas Vegas$70K
- Catherine McCarthyReno$68K
- Kimberly AdamsLas Vegas$51K
- Badi EghterafiHenderson$38K
- Francisco DofelizReno$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.